: Pfizer confronts ‘peak of anti-vaccination rhetoric’ as shares rebound
Cost-saving program "will touch all parts of the business" but won't affect Seagen acquisition, Pfizer says.
Cost-saving program "will touch all parts of the business" but won't affect Seagen acquisition, Pfizer says.